Global Microneedles for Trans & Intradermal Drug Delivery Market Growth 2025-2031

January 2025 | 88 pages | ID: GCFB05BD77EFEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Microneedles for Trans & Intradermal Drug Delivery market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Microneedles for Trans & Intradermal Drug Delivery is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Microneedles for Trans & Intradermal Drug Delivery is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Microneedles for Trans & Intradermal Drug Delivery is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Microneedles for Trans & Intradermal Drug Delivery players cover Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, Dr. Prausnitz Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Microneedles for Trans & Intradermal Drug Delivery Industry Forecast” looks at past sales and reviews total world Microneedles for Trans & Intradermal Drug Delivery sales in 2024, providing a comprehensive analysis by region and market sector of projected Microneedles for Trans & Intradermal Drug Delivery sales for 2025 through 2031. With Microneedles for Trans & Intradermal Drug Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microneedles for Trans & Intradermal Drug Delivery industry.

This Insight Report provides a comprehensive analysis of the global Microneedles for Trans & Intradermal Drug Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microneedles for Trans & Intradermal Drug Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microneedles for Trans & Intradermal Drug Delivery market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microneedles for Trans & Intradermal Drug Delivery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microneedles for Trans & Intradermal Drug Delivery.

This report presents a comprehensive overview, market shares, and growth opportunities of Microneedles for Trans & Intradermal Drug Delivery market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Solid Microneedles
• Hollow Microneedles
• Dissolvable Microneedles

Segmentation by Application:

• Drugs
• Vaccines
• Proteins
• Peptides
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Becton Dickinson
• Nanopass Technologies
• Radius Health
• Clearside Biomedical
• Dr. Prausnitz Group
• Zosano Pharma
• Corium International
• Circassia
• Valeritas, Inc.
• BD Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Microneedles for Trans & Intradermal Drug Delivery market?

What factors are driving Microneedles for Trans & Intradermal Drug Delivery market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Microneedles for Trans & Intradermal Drug Delivery market opportunities vary by end market size?

How does Microneedles for Trans & Intradermal Drug Delivery break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Microneedles for Trans & Intradermal Drug Delivery by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Microneedles for Trans & Intradermal Drug Delivery by Country/Region, 2020, 2024 & 2031
2.2 Microneedles for Trans & Intradermal Drug Delivery Segment by Type
  2.2.1 Solid Microneedles
  2.2.2 Hollow Microneedles
  2.2.3 Dissolvable Microneedles
2.3 Microneedles for Trans & Intradermal Drug Delivery Sales by Type
  2.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2020-2025)
  2.3.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Microneedles for Trans & Intradermal Drug Delivery Sale Price by Type (2020-2025)
2.4 Microneedles for Trans & Intradermal Drug Delivery Segment by Application
  2.4.1 Drugs
  2.4.2 Vaccines
  2.4.3 Proteins
  2.4.4 Peptides
  2.4.5 Others
2.5 Microneedles for Trans & Intradermal Drug Delivery Sales by Application
  2.5.1 Global Microneedles for Trans & Intradermal Drug Delivery Sale Market Share by Application (2020-2025)
  2.5.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Microneedles for Trans & Intradermal Drug Delivery Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Microneedles for Trans & Intradermal Drug Delivery Breakdown Data by Company
  3.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Annual Sales by Company (2020-2025)
  3.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Company (2020-2025)
3.2 Global Microneedles for Trans & Intradermal Drug Delivery Annual Revenue by Company (2020-2025)
  3.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Company (2020-2025)
  3.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Company (2020-2025)
3.3 Global Microneedles for Trans & Intradermal Drug Delivery Sale Price by Company
3.4 Key Manufacturers Microneedles for Trans & Intradermal Drug Delivery Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Microneedles for Trans & Intradermal Drug Delivery Product Location Distribution
  3.4.2 Players Microneedles for Trans & Intradermal Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR MICRONEEDLES FOR TRANS & INTRADERMAL DRUG DELIVERY BY GEOGRAPHIC REGION

4.1 World Historic Microneedles for Trans & Intradermal Drug Delivery Market Size by Geographic Region (2020-2025)
  4.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Microneedles for Trans & Intradermal Drug Delivery Market Size by Country/Region (2020-2025)
  4.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Annual Revenue by Country/Region (2020-2025)
4.3 Americas Microneedles for Trans & Intradermal Drug Delivery Sales Growth
4.4 APAC Microneedles for Trans & Intradermal Drug Delivery Sales Growth
4.5 Europe Microneedles for Trans & Intradermal Drug Delivery Sales Growth
4.6 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Growth

5 AMERICAS

5.1 Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Country
  5.1.1 Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2020-2025)
  5.1.2 Americas Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2020-2025)
5.2 Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2020-2025)
5.3 Americas Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Region
  6.1.1 APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2020-2025)
  6.1.2 APAC Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2020-2025)
6.2 APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2020-2025)
6.3 APAC Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Microneedles for Trans & Intradermal Drug Delivery by Country
  7.1.1 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2020-2025)
  7.1.2 Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2020-2025)
7.2 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2020-2025)
7.3 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery by Country
  8.1.1 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2020-2025)
8.2 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2020-2025)
8.3 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Microneedles for Trans & Intradermal Drug Delivery
10.3 Manufacturing Process Analysis of Microneedles for Trans & Intradermal Drug Delivery
10.4 Industry Chain Structure of Microneedles for Trans & Intradermal Drug Delivery

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Microneedles for Trans & Intradermal Drug Delivery Distributors
11.3 Microneedles for Trans & Intradermal Drug Delivery Customer

12 WORLD FORECAST REVIEW FOR MICRONEEDLES FOR TRANS & INTRADERMAL DRUG DELIVERY BY GEOGRAPHIC REGION

12.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size Forecast by Region
  12.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Forecast by Region (2026-2031)
  12.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Microneedles for Trans & Intradermal Drug Delivery Forecast by Type (2026-2031)
12.7 Global Microneedles for Trans & Intradermal Drug Delivery Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Becton Dickinson
  13.1.1 Becton Dickinson Company Information
  13.1.2 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
  13.1.3 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Becton Dickinson Main Business Overview
  13.1.5 Becton Dickinson Latest Developments
13.2 Nanopass Technologies
  13.2.1 Nanopass Technologies Company Information
  13.2.2 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
  13.2.3 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Nanopass Technologies Main Business Overview
  13.2.5 Nanopass Technologies Latest Developments
13.3 Radius Health
  13.3.1 Radius Health Company Information
  13.3.2 Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
  13.3.3 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Radius Health Main Business Overview
  13.3.5 Radius Health Latest Developments
13.4 Clearside Biomedical
  13.4.1 Clearside Biomedical Company Information
  13.4.2 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
  13.4.3 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Clearside Biomedical Main Business Overview
  13.4.5 Clearside Biomedical Latest Developments
13.5 Dr. Prausnitz Group
  13.5.1 Dr. Prausnitz Group Company Information
  13.5.2 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
  13.5.3 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Dr. Prausnitz Group Main Business Overview
  13.5.5 Dr. Prausnitz Group Latest Developments
13.6 Zosano Pharma
  13.6.1 Zosano Pharma Company Information
  13.6.2 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
  13.6.3 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Zosano Pharma Main Business Overview
  13.6.5 Zosano Pharma Latest Developments
13.7 Corium International
  13.7.1 Corium International Company Information
  13.7.2 Corium International Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
  13.7.3 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Corium International Main Business Overview
  13.7.5 Corium International Latest Developments
13.8 Circassia
  13.8.1 Circassia Company Information
  13.8.2 Circassia Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
  13.8.3 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Circassia Main Business Overview
  13.8.5 Circassia Latest Developments
13.9 Valeritas, Inc.
  13.9.1 Valeritas, Inc. Company Information
  13.9.2 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
  13.9.3 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Valeritas, Inc. Main Business Overview
  13.9.5 Valeritas, Inc. Latest Developments
13.10 BD Medical
  13.10.1 BD Medical Company Information
  13.10.2 BD Medical Microneedles for Trans & Intradermal Drug Delivery Product Portfolios and Specifications
  13.10.3 BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 BD Medical Main Business Overview
  13.10.5 BD Medical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Microneedles forTrans & Intradermal Drug Delivery Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Microneedles forTrans & Intradermal Drug Delivery Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Solid Microneedles
Table 4. Major Players of Hollow Microneedles
Table 5. Major Players of Dissolvable Microneedles
Table 6. Global Microneedles forTrans & Intradermal Drug Delivery Sales byType (2020-2025) & (K Units)
Table 7. Global Microneedles forTrans & Intradermal Drug Delivery Sales Market Share byType (2020-2025)
Table 8. Global Microneedles forTrans & Intradermal Drug Delivery Revenue byType (2020-2025) & ($ million)
Table 9. Global Microneedles forTrans & Intradermal Drug Delivery Revenue Market Share byType (2020-2025)
Table 10. Global Microneedles forTrans & Intradermal Drug Delivery Sale Price byType (2020-2025) & (USD/Unit)
Table 11. Global Microneedles forTrans & Intradermal Drug Delivery Sale by Application (2020-2025) & (K Units)
Table 12. Global Microneedles forTrans & Intradermal Drug Delivery Sale Market Share by Application (2020-2025)
Table 13. Global Microneedles forTrans & Intradermal Drug Delivery Revenue by Application (2020-2025) & ($ million)
Table 14. Global Microneedles forTrans & Intradermal Drug Delivery Revenue Market Share by Application (2020-2025)
Table 15. Global Microneedles forTrans & Intradermal Drug Delivery Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Microneedles forTrans & Intradermal Drug Delivery Sales by Company (2020-2025) & (K Units)
Table 17. Global Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Company (2020-2025)
Table 18. Global Microneedles forTrans & Intradermal Drug Delivery Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Microneedles forTrans & Intradermal Drug Delivery Revenue Market Share by Company (2020-2025)
Table 20. Global Microneedles forTrans & Intradermal Drug Delivery Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Microneedles forTrans & Intradermal Drug Delivery Producing Area Distribution and Sales Area
Table 22. Players Microneedles forTrans & Intradermal Drug Delivery Products Offered
Table 23. Microneedles forTrans & Intradermal Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Microneedles forTrans & Intradermal Drug Delivery Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Microneedles forTrans & Intradermal Drug Delivery Sales Market Share Geographic Region (2020-2025)
Table 28. Global Microneedles forTrans & Intradermal Drug Delivery Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Microneedles forTrans & Intradermal Drug Delivery Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Microneedles forTrans & Intradermal Drug Delivery Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Country/Region (2020-2025)
Table 32. Global Microneedles forTrans & Intradermal Drug Delivery Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Microneedles forTrans & Intradermal Drug Delivery Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Microneedles forTrans & Intradermal Drug Delivery Sales by Country (2020-2025) & (K Units)
Table 35. Americas Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Country (2020-2025)
Table 36. Americas Microneedles forTrans & Intradermal Drug Delivery Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Microneedles forTrans & Intradermal Drug Delivery Sales byType (2020-2025) & (K Units)
Table 38. Americas Microneedles forTrans & Intradermal Drug Delivery Sales by Application (2020-2025) & (K Units)
Table 39. APAC Microneedles forTrans & Intradermal Drug Delivery Sales by Region (2020-2025) & (K Units)
Table 40. APAC Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Region (2020-2025)
Table 41. APAC Microneedles forTrans & Intradermal Drug Delivery Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Microneedles forTrans & Intradermal Drug Delivery Sales byType (2020-2025) & (K Units)
Table 43. APAC Microneedles forTrans & Intradermal Drug Delivery Sales by Application (2020-2025) & (K Units)
Table 44. Europe Microneedles forTrans & Intradermal Drug Delivery Sales by Country (2020-2025) & (K Units)
Table 45. Europe Microneedles forTrans & Intradermal Drug Delivery Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Microneedles forTrans & Intradermal Drug Delivery Sales byType (2020-2025) & (K Units)
Table 47. Europe Microneedles forTrans & Intradermal Drug Delivery Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Microneedles forTrans & Intradermal Drug Delivery Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Microneedles forTrans & Intradermal Drug Delivery Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Microneedles forTrans & Intradermal Drug Delivery Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Microneedles forTrans & Intradermal Drug Delivery Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Microneedles forTrans & Intradermal Drug Delivery
Table 53. Key Market Challenges & Risks of Microneedles forTrans & Intradermal Drug Delivery
Table 54. Key IndustryTrends of Microneedles forTrans & Intradermal Drug Delivery
Table 55. Microneedles forTrans & Intradermal Drug Delivery Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Microneedles forTrans & Intradermal Drug Delivery Distributors List
Table 58. Microneedles forTrans & Intradermal Drug Delivery Customer List
Table 59. Global Microneedles forTrans & Intradermal Drug Delivery SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Microneedles forTrans & Intradermal Drug Delivery RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Microneedles forTrans & Intradermal Drug Delivery SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Microneedles forTrans & Intradermal Drug Delivery Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Microneedles forTrans & Intradermal Drug Delivery SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Microneedles forTrans & Intradermal Drug Delivery Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Microneedles forTrans & Intradermal Drug Delivery SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Microneedles forTrans & Intradermal Drug Delivery RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Microneedles forTrans & Intradermal Drug Delivery SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Microneedles forTrans & Intradermal Drug Delivery RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Microneedles forTrans & Intradermal Drug Delivery SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Microneedles forTrans & Intradermal Drug Delivery RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Microneedles forTrans & Intradermal Drug Delivery SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Microneedles forTrans & Intradermal Drug Delivery RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Becton Dickinson Basic Information, Microneedles forTrans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 74. Becton Dickinson Microneedles forTrans & Intradermal Drug Delivery Product Portfolios and Specifications
Table 75. Becton Dickinson Microneedles forTrans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Becton Dickinson Main Business
Table 77. Becton Dickinson Latest Developments
Table 78. NanopassTechnologies Basic Information, Microneedles forTrans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 79. NanopassTechnologies Microneedles forTrans & Intradermal Drug Delivery Product Portfolios and Specifications
Table 80. NanopassTechnologies Microneedles forTrans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. NanopassTechnologies Main Business
Table 82. NanopassTechnologies Latest Developments
Table 83. Radius Health Basic Information, Microneedles forTrans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 84. Radius Health Microneedles forTrans & Intradermal Drug Delivery Product Portfolios and Specifications
Table 85. Radius Health Microneedles forTrans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Radius Health Main Business
Table 87. Radius Health Latest Developments
Table 88. Clearside Biomedical Basic Information, Microneedles forTrans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 89. Clearside Biomedical Microneedles forTrans & Intradermal Drug Delivery Product Portfolios and Specifications
Table 90. Clearside Biomedical Microneedles forTrans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Clearside Biomedical Main Business
Table 92. Clearside Biomedical Latest Developments
Table 93. Dr. Prausnitz Group Basic Information, Microneedles forTrans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 94. Dr. Prausnitz Group Microneedles forTrans & Intradermal Drug Delivery Product Portfolios and Specifications
Table 95. Dr. Prausnitz Group Microneedles forTrans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Dr. Prausnitz Group Main Business
Table 97. Dr. Prausnitz Group Latest Developments
Table 98. Zosano Pharma Basic Information, Microneedles forTrans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 99. Zosano Pharma Microneedles forTrans & Intradermal Drug Delivery Product Portfolios and Specifications
Table 100. Zosano Pharma Microneedles forTrans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Zosano Pharma Main Business
Table 102. Zosano Pharma Latest Developments
Table 103. Corium International Basic Information, Microneedles forTrans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 104. Corium International Microneedles forTrans & Intradermal Drug Delivery Product Portfolios and Specifications
Table 105. Corium International Microneedles forTrans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Corium International Main Business
Table 107. Corium International Latest Developments
Table 108. Circassia Basic Information, Microneedles forTrans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 109. Circassia Microneedles forTrans & Intradermal Drug Delivery Product Portfolios and Specifications
Table 110. Circassia Microneedles forTrans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Circassia Main Business
Table 112. Circassia Latest Developments
Table 113. Valeritas, Inc. Basic Information, Microneedles forTrans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 114. Valeritas, Inc. Microneedles forTrans & Intradermal Drug Delivery Product Portfolios and Specifications
Table 115. Valeritas, Inc. Microneedles forTrans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Valeritas, Inc. Main Business
Table 117. Valeritas, Inc. Latest Developments
Table 118. BD Medical Basic Information, Microneedles forTrans & Intradermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 119. BD Medical Microneedles forTrans & Intradermal Drug Delivery Product Portfolios and Specifications
Table 120. BD Medical Microneedles forTrans & Intradermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. BD Medical Main Business
Table 122. BD Medical Latest Developments



LIST OFFIGURES

Figure 1. Picture of Microneedles forTrans & Intradermal Drug Delivery
Figure 2. Microneedles forTrans & Intradermal Drug Delivery Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Microneedles forTrans & Intradermal Drug Delivery Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Microneedles forTrans & Intradermal Drug Delivery Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Microneedles forTrans & Intradermal Drug Delivery Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Country/Region (2024)
Figure 10. Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Solid Microneedles
Figure 12. Product Picture of Hollow Microneedles
Figure 13. Product Picture of Dissolvable Microneedles
Figure 14. Global Microneedles forTrans & Intradermal Drug Delivery Sales Market Share byType in 2025
Figure 15. Global Microneedles forTrans & Intradermal Drug Delivery Revenue Market Share byType (2020-2025)
Figure 16. Microneedles forTrans & Intradermal Drug Delivery Consumed in Drugs
Figure 17. Global Microneedles forTrans & Intradermal Drug Delivery Market: Drugs (2020-2025) & (K Units)
Figure 18. Microneedles forTrans & Intradermal Drug Delivery Consumed in Vaccines
Figure 19. Global Microneedles forTrans & Intradermal Drug Delivery Market: Vaccines (2020-2025) & (K Units)
Figure 20. Microneedles forTrans & Intradermal Drug Delivery Consumed in Proteins
Figure 21. Global Microneedles forTrans & Intradermal Drug Delivery Market: Proteins (2020-2025) & (K Units)
Figure 22. Microneedles forTrans & Intradermal Drug Delivery Consumed in Peptides
Figure 23. Global Microneedles forTrans & Intradermal Drug Delivery Market: Peptides (2020-2025) & (K Units)
Figure 24. Microneedles forTrans & Intradermal Drug Delivery Consumed in Others
Figure 25. Global Microneedles forTrans & Intradermal Drug Delivery Market: Others (2020-2025) & (K Units)
Figure 26. Global Microneedles forTrans & Intradermal Drug Delivery Sale Market Share by Application (2024)
Figure 27. Global Microneedles forTrans & Intradermal Drug Delivery Revenue Market Share by Application in 2025
Figure 28. Microneedles forTrans & Intradermal Drug Delivery Sales by Company in 2025 (K Units)
Figure 29. Global Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Company in 2025
Figure 30. Microneedles forTrans & Intradermal Drug Delivery Revenue by Company in 2025 ($ millions)
Figure 31. Global Microneedles forTrans & Intradermal Drug Delivery Revenue Market Share by Company in 2025
Figure 32. Global Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Microneedles forTrans & Intradermal Drug Delivery Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Microneedles forTrans & Intradermal Drug Delivery Sales 2020-2025 (K Units)
Figure 35. Americas Microneedles forTrans & Intradermal Drug Delivery Revenue 2020-2025 ($ millions)
Figure 36. APAC Microneedles forTrans & Intradermal Drug Delivery Sales 2020-2025 (K Units)
Figure 37. APAC Microneedles forTrans & Intradermal Drug Delivery Revenue 2020-2025 ($ millions)
Figure 38. Europe Microneedles forTrans & Intradermal Drug Delivery Sales 2020-2025 (K Units)
Figure 39. Europe Microneedles forTrans & Intradermal Drug Delivery Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Microneedles forTrans & Intradermal Drug Delivery Sales 2020-2025 (K Units)
Figure 41. Middle East & Africa Microneedles forTrans & Intradermal Drug Delivery Revenue 2020-2025 ($ millions)
Figure 42. Americas Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Country in 2025
Figure 43. Americas Microneedles forTrans & Intradermal Drug Delivery Revenue Market Share by Country (2020-2025)
Figure 44. Americas Microneedles forTrans & Intradermal Drug Delivery Sales Market Share byType (2020-2025)
Figure 45. Americas Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Application (2020-2025)
Figure 46. United States Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Region in 2025
Figure 51. APAC Microneedles forTrans & Intradermal Drug Delivery Revenue Market Share by Region (2020-2025)
Figure 52. APAC Microneedles forTrans & Intradermal Drug Delivery Sales Market Share byType (2020-2025)
Figure 53. APAC Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Application (2020-2025)
Figure 54. China Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 58. India Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 60. ChinaTaiwan Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Country in 2025
Figure 62. Europe Microneedles forTrans & Intradermal Drug Delivery Revenue Market Share by Country (2020-2025)
Figure 63. Europe Microneedles forTrans & Intradermal Drug Delivery Sales Market Share byType (2020-2025)
Figure 64. Europe Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Application (2020-2025)
Figure 65. Germany Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 66.France Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Microneedles forTrans & Intradermal Drug Delivery Sales Market Share byType (2020-2025)
Figure 72. Middle East & Africa Microneedles forTrans & Intradermal Drug Delivery Sales Market Share by Application (2020-2025)
Figure 73. Egypt Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 76.Turkey Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Microneedles forTrans & Intradermal Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Microneedles forTrans & Intradermal Drug Delivery in 2025
Figure 79. Manufacturing Process Analysis of Microneedles forTrans & Intradermal Drug Delivery
Figure 80. Industry Chain Structure of Microneedles forTrans & Intradermal Drug Delivery
Figure 81. Channels of Distribution
Figure 82. Global Microneedles forTrans & Intradermal Drug Delivery Sales MarketForecast by Region (2026-2031)
Figure 83. Global Microneedles forTrans & Intradermal Drug Delivery Revenue Market ShareForecast by Region (2026-2031)
Figure 84. Global Microneedles forTrans & Intradermal Drug Delivery Sales Market ShareForecast byType (2026-2031)
Figure 85. Global Microneedles forTrans & Intradermal Drug Delivery Revenue Market ShareForecast byType (2026-2031)
Figure 86. Global Microneedles forTrans & Intradermal Drug Delivery Sales Market ShareForecast by Application (2026-2031)
Figure 87. Global Microneedles forTrans & Intradermal Drug Delivery Revenue Market ShareForecast by Application (2026-2031)